Literature DB >> 20082599

ABCC2/Abcc2: a multispecific transporter with dominant excretory functions.

Katalin Jemnitz1, Krisztina Heredi-Szabo, Judit Janossy, Eniko Ioja, Laszlo Vereczkey, Peter Krajcsi.   

Abstract

ABCC2/Abcc2 (MRP2/Mrp2) is expressed at major physiological barriers, such as the canalicular membrane of liver cells, kidney proximal tubule epithelial cells, enterocytes of the small and large intestine, and syncytiotrophoblast of the placenta. ABCC2/Abcc2 always localizes in the apical membranes. Although ABCC2/Abcc2 transports a variety of amphiphilic anions that belong to different classes of molecules, such as endogenous compounds (e.g., bilirubin-glucuronides), drugs, toxic chemicals, nutraceuticals, and their conjugates, it displays a preference for phase II conjugates. Phenotypically, the most obvious consequence of mutations in ABCC2 that lead to Dubin-Johnson syndrome is conjugate hyperbilirubinemia. ABCC2/Abcc2 harbors multiple binding sites and displays complex transport kinetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082599     DOI: 10.3109/03602530903491741

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  34 in total

Review 1.  Innovative treatment for hepatocellular carcinoma (HCC).

Authors:  Junichi Kaneko; Takashi Kokudo; Yoshinori Inagaki; Kiyoshi Hasegawa
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-22

2.  Proteomic analysis of the enterocyte brush border.

Authors:  Russell E McConnell; Andrew E Benesh; Suli Mao; David L Tabb; Matthew J Tyska
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-17       Impact factor: 4.052

Review 3.  A perspective on efflux transport proteins in the liver.

Authors:  K Köck; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2012-09-05       Impact factor: 6.875

4.  Effects of Tea Catechins on Cancer Signaling Pathways.

Authors:  Chung S Yang; Hong Wang; Jayson X Chen; Jinsong Zhang
Journal:  Enzymes       Date:  2014

5.  Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.

Authors:  Chii Chii Chew; Salby Ng; Yun Lee Chee; Teng Wai Koo; Ming Hui Liew; Evelyn Li-Ching Chee; Pilar Modamio; Cecilia Fernández; Eduardo L Mariño; Ignacio Segarra
Journal:  Invest New Drugs       Date:  2017-03-11       Impact factor: 3.850

6.  Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.

Authors:  Ming Hui Liew; Salby Ng; Chii Chii Chew; Teng Wai Koo; Yun Lee Chee; Evelyn Li-Ching Chee; Pilar Modamio; Cecilia Fernández; Eduardo L Mariño; Ignacio Segarra
Journal:  Invest New Drugs       Date:  2017-01-09       Impact factor: 3.850

Review 7.  Effect of Liver Disease on Hepatic Transporter Expression and Function.

Authors:  Nilay Thakkar; Jason R Slizgi; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2017-04-30       Impact factor: 3.534

8.  Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution.

Authors:  Gennadiy Kovtunovych; Michael A Eckhaus; Manik C Ghosh; Hayden Ollivierre-Wilson; Tracey A Rouault
Journal:  Blood       Date:  2010-09-15       Impact factor: 22.113

Review 9.  Inherited disorders of bilirubin clearance.

Authors:  Naureen Memon; Barry I Weinberger; Thomas Hegyi; Lauren M Aleksunes
Journal:  Pediatr Res       Date:  2015-11-23       Impact factor: 3.756

10.  Hepatobiliary transport in health and disease.

Authors:  Jeannie Chan; John L Vandeberg
Journal:  Clin Lipidol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.